Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab vs Azathioprine for Remission Maintenance in PACNS
NCT07902492Phase 2Not yet recruiting
- Sponsor
- Centre Hospitalier Sainte-Anne
- Start
- Jan 2027
- Primary completion
- Jan 2030
01
Overview
A Phase 2 trial of rituximab in primary angiitis of the central nervous system (PACNS), sponsored by Centre Hospitalier Sainte-Anne. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
rituximab
03
Conditions
primary angiitis of the central nervous system (PACNS)
Beyond the preview
Go deeper on NCT07902492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07902492.